Figure S1 presents the difference spectra for control versus the four breast cancer subtypes Luminal A (Hr+/Her2−), Luminal B (Hr+/Her2+), HER2 enriched (Hr−/Her2+), and TNBC (Hr−/Her2−), highlighting key spectral changes associated with each disease subtype. This evidence concerns the gene HR and breast carcinoma.